参考文献/References:
[1]Bedoschi G,Navarro PA,Oktay K.Chemotherapy- induced damage to ovary: mechanisms and clinical impact[J].Future Oncol,2016,12(20):2333-2344.[2]刘艳,赵婷,梅鲜鲜,等.系统性红斑狼疮对卵巢功能的影响及中医辨治思路[J].中华中医药杂志,2021,36(3):1500-1503.[3]吉瑞雪.蒙药暖宫七味散治疗原发性痛经的临床疗效[J].中国民族医药杂志,2021,27(11):28-29.[4]梁昕,赵可宁.夏桂成教授运用补肾调经法治疗卵巢储备功能下降不孕症的经验[J].河北中医药学报,2016,31(3): 54-57.[5]张小莹,崔晓萍,肖新春,等.滋阴毓宫方联合助阳暖宫方治疗早发性卵巢功能不全的临床研究[J].现代中药研究与实践,2021,35(1):73-76.[6]周慧,王雅琴,王静,吴克明.吴克明教授治疗卵巢早衰经验总结[J].云南中医中药杂志,2019,40(2):1-3.[7]滕秀香.卵巢早衰辨证治疗中药配伍研究[J].北京中医药,2015,34(4):285-287.[8]朱景茹,陈姝婷,卓泽伟,等.补肾健脾方对卵巢早衰大鼠下丘脑-垂体-性腺轴功能的影响[J].福建中医药,2021,52(2):14-17.[9]Sullivan SD,Sarrel PM,Nelson LM.Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause menopause[J].Fertility & Sterility,2016,106(7):1588-1599.[10]刘柳青,刘雁峰,王悦竹,等.卵巢储备功能下降中医证型特点及用药规律文献挖掘研究[J].中国中医药信息杂志,2021,28(6):33-38.[11]Benetti-Pinto CL,de Almeida DM,Makuch MY.Quality of life in women with premature ovarian failure[J].Gynecol Endocrinol,2011,27(9):645-649.[12]European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI,Webber L,Davies M,et al.ESHRE Guideline: management of women with premature ovarian insufficiency[J].Hum Reprod,2016,31(5):926-937.[13]Laven JS.Primary ovarian insufficiency[J].Semin Reprod Med,2016,34(4):230-234. [14]Jankowska K.Premature ovarian failure[J].Prz Menopauzalny,2017,16(2):51-56.[15]Demayo S,Giannone L,Monastero A,et al.Reality of premature ovarian failure in Argentina[J].Rev Assoc Med Bras (1992),2019,65(3):419-423.[16]胥风华,侯亚宁,葛鹏玲,等.卵巢早衰中医治疗特色[J].辽宁中医药大学学报,2020,22(1):25-28.[17]Naumova I,Castelo-Branco C,Casals G.Psychological Issues and Sexual Function in Women with Different Infertility Causes: Focus on Polycystic Ovary Syndrome[J].Reprod Sci,2021,28(10):2830-2838.[18]Rodriguez-Paris D,Remlinger-Molenda A,Kurzawa R,et al.Psychiatric disorders in women with polycystic ovary syndrome.Wystrome.s in womenńpsychicznych u kobiet z zespospo zespospobiet z zespocy[J].Psychiatr Pol,2019,53(4):955-966.[19]Rosenfield RL,Ehrmann DA.The Pathogenesis of Polycystic Ovary Syndrome(PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited[J].Endocr Rev,2016,37(5):467-520.[20]张庆蔚,赵旭涛.从三焦论治多囊卵巢综合征理论探析[J].山东中医药大学学报,2021,45(2):195-198.[21]李丽华,李文艳,周婷婷.滋阴助阳方联合二甲双胍治疗多囊卵巢综合征临床研究[J].新中医,2021,53(6):67-70.[22]刘亚果.加味补肾调肝汤联合暖宫孕子胶囊治疗多囊卵巢综合征患者的临床研究[J].辽宁医学杂志,2017,31(6):23-24.[23]张伟,韩晶.补肾活血方对肾虚血瘀型多囊卵巢综合征导致排卵障碍性不孕症患者卵巢功能及生殖内分泌指标的影响[J].黑龙江医药,2021,34(2):368-370.[24]李凤英,翟婷婷,杨华,等.基于PI3K/Akt信号通路探讨温肾助阳调周法对肾阳虚证PCOS患者性激素、胰岛素及排卵的影响[J].中国实验方剂学杂志,2020,26(3):84-89.[25]辛俊,郭慧梅,高希焕,等.苍附导痰汤结合达英-35治疗多囊卵巢综合征疗效观察[J].现代中西医结合杂志,2017,26(2):197-199.[26]张爽爽,夏庆民,郑荣寿,等.中国2010年卵巢癌发病与死亡分析[J].中国肿瘤,2016,25(3):169-173.[27]Muto S,Takagi H,Owada Y,et al.Serum Nitric Oxide as a Predictive Biomarker for Bevacizumab in Non-small Cell Lung Cancer Patients[J].Anticancer Res,2017,37(6):3169-3174.[28]秦竹,肖乔,韩凤娟.从络病理论探讨卵巢癌的病机及理冲生髓饮治疗思路[J].中华中医药杂志,2017,32(7): 2879-2881.[29]Bruckner HW,Gurell D,Hirschfeld A.Bevacizumab Added to Moderate-dose Chemotherapy for Refractory Uterine Cancer[J].Anticancer Res,2018,38(1):547-552.[30]徐国暑,谢鑫灵,陈嘉斌,等.柴可群从肝论治卵巢癌经验总结[J].中医肿瘤学杂志,2021,3(1):38-42.[31]潘金丽.益气健脾养血汤联合多西紫杉醇与顺铂治疗晚期卵巢癌[J].中医学报,2018,33(7):1186-1189.[32]蔡昱,黄上,朱克俭.益气养阴汤联合贝伐珠单抗治疗卵巢癌疗效及对血清HDGF、MIF、TGF-β1表达的影响[J].现代中西医结合杂志,2020,29(24):2684-2687.[33]宋晓婕.扶正固肾汤对老年卵巢癌术后患者外周血T淋巴细胞亚群及肿瘤标志物的影响[J].中国老年学杂志,2020,40(10):67-70.[34]王芳芳,李益萍,蒲腾达,等.桂枝茯苓汤对卵巢癌术后患者外周血T淋巴细胞亚群、血清肿瘤标志物及凝血水平变化的影响[J].世界中医药,2019,14(8):2067-2072.[35]鲁佩佩,辛文秀.龙葵当归三棱汤治疗卵巢癌临床疗效及对免疫指标及炎性因子的影响[J].中华中医药学刊,2020,38(3):242-245.